Management of Hyperphosphatemia

Dietary and Pharmacological Interventions

• The National Kidney Foundation recommends dietary phosphate restriction as the first-line approach for patients with elevated phosphate levels 1
• The Kidney International guideline suggests phosphate binders should be used when dietary restriction is insufficient to control hyperphosphatemia 2
• The Kidney International guideline also recommends restricting calcium-based phosphate binders in patients with persistent hyperphosphatemia to prevent hypercalcemia 2
• The American Journal of Kidney Diseases recommends limiting phosphate intake through dietary restriction 1
• The American Journal of Kidney Diseases advises avoiding aluminum-containing compounds as phosphate binders due to the risk of aluminum toxicity 4

Special Patient Populations

• The American Journal of Kidney Diseases recommends that for patients with osteomalacia, hyperphosphatemia should be corrected first before considering vitamin D supplementation 1, 4, 5
• The Nature Reviews Nephrology guideline indicates that for patients with X-linked hypophosphatemia, vitamin D3 along with phosphate supplements would be indicated 6

Monitoring and Adjustment

• The American Journal of Kidney Diseases recommends that if vitamin D must be given after phosphate control is achieved, serum phosphate and calcium levels should be monitored at least weekly during initial supplementation 5
• The Praxis Medical Insights guideline suggests monitoring serum phosphate and calcium levels at least weekly during initial supplementation 3